Dr Leila Rastegar develops analytical methodologies by using Liquid-Chromatography-Mass Spectrometry (LC- MS/MS) techniques to support the research in anti- doping science within the DCC, commanding a good work ethic and to be an advocate for Good Laboratory Practice (GLP) on all occasions. Providing recognised specialist analytical expertise for the LC-technologies where the primary focus is on operating both as an individual and in a team, they contribute to the smooth running of the DCC and conduct confirmation procedures and/or validation as required by the Head of the Drug Control Centre.

They are responsive to changing priorities within an evolving environment /context, maximising the efficiency of the analytical service being provided. Fostering a stimulating, innovative and inclusive cultural environment across Kings Forensics enabling colleagues to thrive and develop, ensuring that processes and policies are followed and are visible, accessible, and transparent.

Publications:

• https://pubmed.ncbi.nlm.nih.gov/36056015/
• https://pubmed.ncbi.nlm.nih.gov/30030996/
• https://www.cabidigitallibrary.org/doi/full/10.5555/20210367958